Loading...
Indian Pharmaceutical Exporter · #3 for Bromhexine · $300.0K export value · DGFT Verified
Maxford Healthcare is the #3 Indian exporter of Bromhexine with $300.0K in export value and 6 verified shipments. Maxford Healthcare holds a 1.8% market share in Bromhexine exports across 1 countries.
| FIJI | $701.2K | 21 | 5.9% |
| CHILE | $601.2K | 49 | 5.1% |
| VENEZUELA | $521.1K | 79 | 4.4% |
| IRAN | $500.0K | 10 | 4.2% |
| FRANCE | $488.6K | 34 | 4.1% |
| CAMBODIA | $442.6K | 45 | 3.7% |
India exports Bromhexine to 109 countries. The top destination is ANGOLA (26.0%), followed by AUSTRALIA and MYANMAR.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PRINCE FARMA, LDA | ANGOLA | $1.5M | 30 |
| KHETAN COMPANY LIMITED | MYANMAR | $917.5K | 22 |
| AGIO RUS LLC | RUSSIA | $811.2K | 34 |
| MAKANS LIMITED | FIJI | $500.0K | 10 |
| INOVA PHARMACEUTICALS(AUSTRALIA) PT | AUSTRALIA | $380.4K | 17 |
| OPKO CHILE S.A., | CHILE | $261.7K | 18 |
| INOVA PHARMACEUTICALS(SINGAPORE) PT | SINGAPORE | $233.9K | 17 |
| MEDREICH AUSTRALIA PTY LTD | AUSTRALIA | $215.3K | 62 |
| PLANET PHARMA | FRANCE | $207.3K | 13 |
| YARATEB KHAVARMIANEH CO LTD | IRAN | $100.0K | 2 |
India's Bromhexine is purchased by 530 buyers worldwide. The top buyer is PRINCE FARMA, LDA (ANGOLA), followed by KHETAN COMPANY LIMITED and AGIO RUS LLC.
India exported $10.3M worth of Bromhexine through 1,945 shipments from 288 suppliers to 109 countries, serving 530 buyers globally. Maxford Healthcare contributes $300.0K to this total, accounting for 1.8% of India's Bromhexine exports.
Maxford Healthcare's average Bromhexine shipment value is $50.0K per consignment, based on 6 shipments totaling $300.0K.
Maxford Healthcare ranks #3 among 288 Indian Bromhexine exporters with a 1.8% market share. The top 3 exporters are UMAVIDA PHARMA PRIVATE LIMITED ($2.6M), EMCURE PHARMACEUTICALS LIMITED ($2.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($907.7K). Maxford Healthcare processed 6 shipments to 1 destination countries.
What Maxford Healthcare must comply with to export Bromhexine to its top destination countries
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | MEDREICH LIMITED | $337.7K | 88 | 2 | $3.8K |
| 10 | IPCA LABORATORIES LIMITED | $308.0K | 20 | 3 | $15.4K |
| 3 | MAXFORD HEALTHCARE ★ | $300.0K | 6 | 1 | $50.0K |
| 11 | LABORATE PHARMACEUTICALS INDIA LTD | $287.8K | 12 | 3 | $24.0K |
| 12 | ADCOCK INGRAM LIMITED | $269.6K | 16 | 2 | $16.9K |
Maxford Healthcare ranks #3 among 288 Indian Bromhexine exporters. Average shipment value of $50.0K compared to the market average of $35.7K. The closest competitors by value are MEDREICH LIMITED and IPCA LABORATORIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 303 | 15.6% |
| JNPT | 169 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 164 | 8.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 157 | 8.1% |
| AHEMDABAD ICD | 74 | 3.8% |
| SAHAR AIR | 73 | 3.8% |
| AHEMDABAD AIR ACC (INAMD4) | 72 | 3.7% |
| AHEMDABAD ICD (INSBI6) | 59 | 3.0% |
Latest developments and market context
Detailed market intelligence for Bromhexine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 530+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Maxford Healthcare's Bromhexine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Maxford Healthcare
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Maxford Healthcare.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bromhexine. For current shipment-level data, contact TransData Nexus.